Biolinq secures $100m to launch needle-free glucose monitor
FierceBiotech - 22-Apr-2025Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes
Join the club for FREE to access the whole archive and other member benefits.
San Diego-based health tech firm developing a new generation of wearable biosensors
Biolinq is a San Diego-based healthcare technology company pioneering a novel class of wearable biosensors aimed at transforming metabolic health monitoring. Their flagship product is a coin-sized patch worn on the upper forearm that continuously tracks glucose levels using an array of ultra-small electrochemical sensors embedded just beneath the skin’s surface. Unlike traditional continuous glucose monitors (CGMs), Biolinq’s device operates without introducer needles or subcutaneous implants, offering a less invasive and more comfortable experience for users.
Visit website: https://www.biolinq.com/
Details last updated 05-May-2025
Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes